These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38162016)

  • 21. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus.
    Brethauer SA; Aminian A; Romero-Talamás H; Batayyah E; Mackey J; Kennedy L; Kashyap SR; Kirwan JP; Rogula T; Kroh M; Chand B; Schauer PR
    Ann Surg; 2013 Oct; 258(4):628-36; discussion 636-7. PubMed ID: 24018646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery--who fails in the early postoperative course?
    Jurowich C; Thalheimer A; Hartmann D; Bender G; Seyfried F; Germer CT; Wichelmann C
    Obes Surg; 2012 Oct; 22(10):1521-6. PubMed ID: 22588846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statistical models to predict type 2 diabetes remission after bariatric surgery.
    Ramos-Levi AM; Matia P; Cabrerizo L; Barabash A; Sanchez-Pernaute A; Calle-Pascual AL; Torres AJ; Rubio MA
    J Diabetes; 2014 Sep; 6(5):472-7. PubMed ID: 24433454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of type-2 diabetes remission following bariatric surgery after a two-year follow-up.
    AbdAlla Salman M; Rabiee A; Salman A; Elewa A; Tourky M; Mahmoud AA; Moustafa A; El-Din Shaaban H; Ismail AA; Noureldin K; Issa M; Farah M; Barbary H; Elhaj MGF; Omar HSE
    Asian J Surg; 2022 Dec; 45(12):2645-2650. PubMed ID: 35256262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year effectiveness of bariatric surgery on disease remission, weight loss, and changes of metabolic parameters in obese patients with type 2 diabetes: A population-based propensity score-matched cohort study.
    Wu T; Wong SKH; Law BTT; Grieve E; Wu O; Tong DKH; Leung DKW; Lam CLK; Wong CKH
    Diabetes Metab Res Rev; 2020 Mar; 36(3):e3236. PubMed ID: 31912598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program: Bariatric Surgical Risk/Benefit Calculator: 1-year comorbidity remission.
    Grieco A; Huffman KM; Cohen ME; Hall BL; Morton JM; Ko CY
    Surg Obes Relat Dis; 2024 Mar; 20(3):275-282. PubMed ID: 37867047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining and Using Preoperative Predictors of Diabetic Remission Following Bariatric Surgery.
    Stallard R; Sahai V; Drover JW; Chun S; Keresztes C
    JPEN J Parenter Enteral Nutr; 2018 Mar; 42(3):573-580. PubMed ID: 29187047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy in type 2 diabetes mellitus remission in patients undergoing bariatric surgery.
    Pereyra-García Castro FM; Oliva García JG; García Nuñez MA; García Bray BF; Suarez Llanos JP; Moneva Arce ME; Palacio Abizanda JE
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Jan; 66(1):56-61. PubMed ID: 30392998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice.
    Amouyal C; Castel J; Guay C; Lacombe A; Denom J; Migrenne-Li S; Rouault C; Marquet F; Georgiadou E; Stylianides T; Luquet S; Le Stunff H; Scharfmann R; Clément K; Rutter GA; Taboureau O; Magnan C; Regazzi R; Andreelli F
    EBioMedicine; 2020 Aug; 58():102895. PubMed ID: 32739864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques.
    Robert M; Ferrand-Gaillard C; Disse E; Espalieu P; Simon C; Laville M; Gouillat C; Thivolet C
    Obes Surg; 2013 Jun; 23(6):770-5. PubMed ID: 23355293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in whole blood gene expression in obese subjects with type 2 diabetes following bariatric surgery: a pilot study.
    Berisha SZ; Serre D; Schauer P; Kashyap SR; Smith JD
    PLoS One; 2011 Mar; 6(3):e16729. PubMed ID: 21423737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in Global Transcriptional Profiling of Women Following Obesity Surgery Bypass.
    Pinhel MAS; Noronha NY; Nicoletti CF; de Oliveira BAP; Cortes-Oliveira C; Pinhanelli VC; Salgado Junior W; Machry AJ; da Silva Junior WA; Souza DRS; Marchini JS; Nonino CB
    Obes Surg; 2018 Jan; 28(1):176-186. PubMed ID: 28735374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of osteopontin predict diabetes remission after bariatric surgery.
    Carbone F; Adami G; Liberale L; Bonaventura A; Bertolotto M; Andraghetti G; Scopinaro N; Camerini GB; Papadia FS; Cordera R; Dallegri F; Montecucco F
    Diabetes Metab; 2019 Sep; 45(4):356-362. PubMed ID: 30268840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Metrics to Assess Type 2 Diabetes After Bariatric Surgery: The "Time-Within-Remission Range".
    Hollanda A; Lecube A; Rubio MA; Sánchez E; Vilarrasa N; Oliva JG; Fernández-Soto ML; Salas-Salvadó J; Ballesteros-Pomar MD; Ciudin A; Torres F; Vidal C; Morales MJ; Valdés S; Pellitero S; Miñambres I; Masmiquel L; Goday A; Suarez L; Flores L; Bueno M; Caixàs A; Bretón I; Cámara R; Olbeyra R; Penso R; José de la Cruz M; Simó-Servat A; Pereyra-García FM; López-Mezquita ET; Gils A; Fidilio E; Bandrés O; Martínez Á; Abuín J; Marques-Pamies M; Tuneu L; Arteaga M; Castañer O; Goñi F; Arrizabalaga C; Botana MA; Calañas A; Rebollo Á
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32283783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.
    Panunzi S; De Gaetano A; Carnicelli A; Mingrone G
    Ann Surg; 2015 Mar; 261(3):459-67. PubMed ID: 25361217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adipose tissue biomarkers involved in early resolution of type 2 diabetes after bariatric surgery.
    Garrido-Sánchez L; Tomé M; Santiago-Fernández C; García-Serrano S; García-Fuentes E; Tinahones FJ
    Surg Obes Relat Dis; 2017 Jan; 13(1):70-77. PubMed ID: 27317602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion.
    Bonaventura A; Liberale L; Carbone F; Scopinaro N; Camerini G; Papadia FS; Cordera R; Dallegri F; Adami GF; Montecucco F
    Nutr Metab Cardiovasc Dis; 2017 May; 27(5):423-429. PubMed ID: 28284664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Preoperative Remission Scores and Diabetes Duration Alone as Predictors of Durable Type 2 Diabetes Remission and Risk of Diabetes Complications After Bariatric Surgery: A Post Hoc Analysis of Participants From the Swedish Obese Subjects Study.
    Sjöholm K; Carlsson LMS; Taube M; le Roux CW; Svensson PA; Peltonen M
    Diabetes Care; 2020 Nov; 43(11):2804-2811. PubMed ID: 32873586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and validation of a nomogram for predicting diabetes remission at 3 months after bariatric surgery in patients with obesity combined with type 2 diabetes mellitus.
    Yuan K; Wu B; Zeng R; Zhou F; Hu R; Wang C
    Diabetes Obes Metab; 2024 Jan; 26(1):169-179. PubMed ID: 37807830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.